Understanding disease biology at the subcellular level is key to precision medicine. High-content phenotypic screening of therapeutic compounds Mechanistic insights into drug-induced subcellular effects Discovery of disease-specific organellar biomarkers Detects subtle,... Read more

ALS is a severe neurodegenerative disorder with no cure and highly variable disease progression, which complicates clinical trial design and therapeutic development. Prognostic tool – Predicts disease progression in ALS patients Clinical trial optimization by patient stratificat... Read more

Frontotemporal dementia (FTD) is difficult to diagnose due to overlapping symptoms with other neurodegenerative disorders, often leading to delays in treatment and clinical trial enrollment. Early and accurate FTD diagnosis – Reduces misdiagnosis and diagnostic delays Clinical t... Read more

A novel therapeutic strategy for Amyotrophic Lateral Sclerosis (ALS) targets impaired microRNA (miRNA) biogenesis—a key molecular defect found in both sporadic and familial ALS. Treatment of ALS Repurposes an FDA-approved drug, reducing development time and regulato... Read more